quadgram

This is a table of type quadgram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

quadgram	frequency
severe acute respiratory syndrome	195
acute respiratory syndrome coronavirus	84
middle east respiratory syndrome	83
in the united states	74
east respiratory syndrome coronavirus	66
as shown in fig	55
porcine reproductive and respiratory	55
reproductive and respiratory syndrome	55
avian infectious bronchitis virus	54
in the presence of	53
of infectious bronchitis virus	53
of severe acute respiratory	51
safety and immunogenicity of	48
in the absence of	45
and respiratory syndrome virus	44
on the other hand	43
and cellular immune responses	42
at the time of	42
modified vaccinia virus ankara	41
of avian infectious bronchitis	39
cd and cd t	38
ck ch lhlj v	37
humoral and cellular immune	35
in the control group	33
in the context of	32
in the present study	32
have been shown to	31
and cd t cells	31
has been shown to	31
in balb c mice	30
as well as the	30
in the case of	29
the end of the	29
as a result of	29
the severe acute respiratory	28
an important role in	28
disease control and prevention	28
the authors declare that	28
at the end of	28
one of the most	28
of west nile virus	27
in vitro and in	26
been shown to be	26
authors declare that they	26
balb c mice were	26
with severe acute respiratory	26
centers for disease control	26
for disease control and	26
in the development of	25
and immunogenicity of a	25
that they have no	24
declare that they have	24
cd t cell responses	24
human immunodeficiency virus type	24
vitro and in vivo	24
in addition to the	24
for the development of	23
rift valley fever virus	23
have no known competing	23
were found to be	23
they have no known	23
the development of a	23
personal relationships that could	22
interests or personal relationships	22
used in this study	22
financial interests or personal	22
that could have appeared	22
relationships that could have	22
to participate in a	22
or personal relationships that	22
competing financial interests or	22
reported in this paper	22
no known competing financial	22
the immune response to	22
could have appeared to	22
safety and efficacy of	22
have appeared to influence	22
known competing financial interests	22
appeared to influence the	22
of the immune response	21
to influence the work	21
work reported in this	21
influence the work reported	21
the work reported in	21
for the prevention of	20
of middle east respiratory	20
with mvaik rsv f	20
immunized with mvaik rsv	20
respiratory syndrome coronavirus spike	20
the world health organization	20
the results showed that	20
on the surface of	20
years old or older	19
to accept a future	19
influenza a h n	19
it is important to	19
rsv g or f	19
the ability of the	19
this article can be	18
a significant increase in	18
incubated for h at	18
for the presence of	18
a future h n	18
future h n vaccine	18
a and nci h	18
of the s protein	18
accept a future h	18
article can be found	18
national institutes of health	18
west nile virus infection	18
play an important role	17
a single dose of	17
cd t cell response	17
of cd t cells	17
a wide range of	17
for the detection of	17
and nci h cells	17
recombinant vesicular stomatitis virus	17
would like to thank	17
was found to be	16
when compared to the	16
feline infectious peritonitis virus	16
it is likely that	16
at the same time	16
cd t cells were	16
in the current study	16
was observed in the	16
of porcine reproductive and	16
between p and p	16
the development of vaccines	16
coronavirus infectious bronchitis virus	16
ibv ck ch lhlj	16
it is possible that	16
of a novel coronavirus	16
peripheral blood mononuclear cells	16
cells were infected with	16
cotton rats immunized with	16
at room temperature for	15
as shown in table	15
was detected in the	15
female balb c mice	15
the spike protein of	15
are shown in fig	15
the results of the	15
the presence of the	15
with mvaik rsv g	15
avian coronavirus infectious bronchitis	15
cov s dna vaccine	15
levels of neutralizing antibodies	15
with the exception of	15
a systematic review and	15
m and s proteins	14
in the frequency of	14
of the immune system	14
this work was supported	14
as a positive control	14
with regard to the	14
at a dose of	14
porcine epidemic diarrhea virus	14
an equal volume of	14
of respiratory syncytial virus	14
adjuvanted h n vaccine	14
for the first time	14
significant increase in the	14
in the control of	14
systematic review and meta	14
rats immunized with mvaik	14
willingness to accept a	14
from each group were	14
was used as a	14
work was supported by	14
is one of the	14
the group that received	14
of the n protein	13
the arkga p vaccine	13
than that of the	13
of vaccine adverse events	13
was added to each	13
of the respiratory tract	13
during the study period	13
human mhc class i	13
the magnitude of the	13
of balb c mice	13
the centers for disease	13
s tr protein expression	13
the wild type virus	13
and respiratory syncytial virus	13
to the development of	13
as part of the	13
important role in the	13
respiratory syndrome coronavirus infection	13
in a number of	13
of the severe acute	13
added to each well	13
in contrast to the	12
heard of h n	12
plays an important role	12
was carried out using	12
pigs vaccinated with prrs	12
rna was extracted from	12
food and drug administration	12
it is possible to	12
as a negative control	12
of human immunodeficiency virus	12
are summarized in table	12
subgroups a and b	12
can be used to	12
min at room temperature	12
purified inactivated sars vaccine	12
of feline infectious peritonitis	12
of a future covid	12
infectious bronchitis virus in	12
of this study was	12
with an equal volume	12
was supported by the	12
at a concentration of	12
and humoral immune responses	12
specific cd t cells	12
the results indicated that	12
innate and adaptive immune	12
health and human services	12
of cd t cell	12
be used as a	12
the immunogenicity of the	12
were detected in the	11
of acute otitis media	11
h n influenza vaccine	11
memory t cell responses	11
poly iclc and le	11
in a mouse model	11
acceptability of a future	11
in mice immunized with	11
the acceptability of a	11
cd t cells in	11
iclc and le poly	11
were added to the	11
in the lungs of	11
a result of the	11
department of health and	11
of the placebo group	11
the development of the	11
a protective immune response	11
on the acceptability of	11
modified live virus vaccine	11
and characterization of a	11
as a means of	11
global vaccine action plan	11
of the spike protein	11
h n influenza virus	11
groups of balb c	11
the wnv e glycoprotein	11
a member of the	11
time of first vaccination	11
of cd and cd	11
the time of first	11
syndrome coronavirus spike protein	11
between cases and controls	11
on day after the	11
views on the acceptability	11
t cell responses in	11
associated with severe acute	11
and le poly iclc	11
we would like to	11
has been reported that	11
studies have shown that	11
highly pathogenic avian influenza	11
mvaik rsv g or	11
high levels of neutralizing	11
have the potential to	11
the protective efficacy of	11
be due to the	11
for min at room	11
the reciprocal of the	11
the majority of the	11
it has been reported	11
the mhc class i	11
with respect to the	11
a vaccine clinical trial	10
in the online version	10
coalition for epidemic preparedness	10
an increase in the	10
respiratory syncytial virus infection	10
a novel coronavirus associated	10
arkga p vaccine candidate	10
a reduction in the	10
viral vector vaccines safety	10
was used as the	10
advisory committee on immunization	10
and patient information leaflet	10
in the united kingdom	10
have been used to	10
it is difficult to	10
rsv subgroups a and	10
against canine visceral leishmaniasis	10
development of a vaccine	10
in the generation of	10
on the use of	10
to porcine reproductive and	10
in a vaccine clinical	10
producing cd t cells	10
a dose of pfu	10
in the form of	10
in the incidence of	10
was added to the	10
of health and human	10
the west nile virus	10
human and animal health	10
novel coronavirus associated with	10
infants and young children	10
animal care and use	10
in the respiratory tract	10
the relative importance of	10
this study was to	10
were observed in the	10
mice were vaccinated with	10
guangzhou and hong kong	10
expression in mammalian cells	10
were obtained from the	10
in the production of	10
intending to take siv	10
patients with severe acute	10
probability of vaccine adverse	10
prescribing information and patient	10
increase in the frequency	10
both humoral and cellular	10
information and patient information	10
coronavirus associated with severe	10
the mucosal immune system	10
spf eggs were inoculated	10
the reaction was stopped	10
ability of the virus	10
the innate immune system	10
h at room temperature	10
the use of the	10
and adaptive immune responses	10
of rift valley fever	10
vaccines safety working group	10
eggs were inoculated with	10
the national institutes of	10
a number of studies	10
vector vaccines safety working	10
immune responses to vaccines	10
type i ifn signaling	10
cd t cells are	9
are those of the	9
to this article can	9
the results of this	9
h n and h	9
on the basis of	9
the total number of	9
incidence of diarrhoea and	9
live attenuated influenza vaccine	9
against west nile virus	9
with this article can	9
the safety and immunogenicity	9
the vaccine and placebo	9
american indian alaska native	9
the frequency of ifn	9
characterization of a novel	9
the presence of a	9
systemic and mucosal immunity	9
in the poultry industry	9
chitosan and its derivatives	9
for the expression of	9
the safety and efficacy	9
immune responses and protection	9
of neutralizing antibodies in	9
been shown to induce	9
to get vaccinated against	9
participate in a covid	9
and the use of	9
to be safe and	9
resources and services administration	9
supplementary data associated with	9
nt antibodies against rsv	9
proteins of avian infectious	9
should be noted that	9
igg and igg a	9
there was a significant	9
in the number of	9
cellular immune responses to	9
cellular and humoral immune	9
incubated for min at	9
level of neutralizing antibodies	9
of the antibody response	9
data associated with this	9
with a dose of	9
rabbit haemorrhagic disease virus	9
immunogenicity and protective efficacy	9
at and days post	9
of vesicular stomatitis virus	9
are shown in table	9
old female balb c	9
for the purpose of	9
in patients with severe	9
institutional animal care and	9
it should be noted	9
a single immunization with	9
the incidence of diarrhoea	9
the fact that the	9
influenza a and b	9
care and use committee	9
health resources and services	9
associated with this article	9
and incubated for h	9
infectious bronchitis virus strain	9
and efficacy of a	9
for h at room	9
g or f protein	9
the role of the	9
have been found to	9
of diarrhoea and mortality	9
at the site of	9
were determined by elisa	9
in mdck pf cells	9
is a determinant of	9
is consistent with the	9
protein of severe acute	9
may be due to	9
n and h n	9
was obtained from the	9
used to evaluate the	9
as the reciprocal of	9
development of vaccines against	9
as well as a	9
of h n vaccine	9
in severe acute respiratory	9
colleagues intending to take	9
the human mhc class	9
the united states and	9
the human immunodeficiency virus	9
development of new vaccines	8
in pigs vaccinated with	8
to that of the	8
template with key considerations	8
humoral immune responses to	8
the pbs control group	8
the trachea and kidney	8
against myxomatosis and rabbit	8
for the induction of	8
were incubated for h	8
in the s and	8
higher than that of	8
we are grateful to	8
used to determine the	8
the vaccine group and	8
were included in the	8
the surface of the	8
has the potential to	8
play a role in	8
as summarized in table	8
the absence of adjuvant	8
immune response against the	8
could be detected in	8
the plates were incubated	8
in response to the	8
in embryonated chicken eggs	8
reduction in viral titer	8
key considerations for a	8
it is estimated that	8
results indicated that the	8
the advisory committee on	8
the s protein is	8
can be found online	8
it has been shown	8
for the evaluation of	8
for epidemic preparedness innovations	8
a role in the	8
those years old or	8
and inactivated h groups	8
the upper respiratory tract	8
the respiratory tract of	8
an international collaborative study	8
committee on immunization practices	8
with fetal bovine serum	8
for use as a	8
and cd t cell	8
considerations for a risk	8
type of immune response	8
specific cd t cell	8
protective immunity in mice	8
in a clinical trial	8
willingness to be vaccinated	8
get vaccinated against covid	8
over the past years	8
room temperature for h	8
chadox mers with tpa	8
be found online at	8
of the advisory committee	8
with different doses of	8
the ad vector is	8
the spike protein is	8
found online at https	8
vaccine and field strains	8
with key considerations for	8
the effectiveness of the	8
both mucosal and systemic	8
mice were challenged with	8
for a risk benefit	8
participate in a vaccine	8
memory cd t cells	8
immune responses induced by	8
supplementary data to this	8
the potential use of	8
are likely to be	8
a live attenuated vaccine	8
to pay for a	8
a means of preventing	8
a risk benefit assessment	8
were observed daily for	8
samples were collected from	8
as well as other	8
blood samples were collected	8
avian infectious bronchitis coronavirus	8
and protective efficacy of	8
of modified vaccinia ankara	8
a safe and effective	8
in cotton rats immunized	8
the duration of the	8
during the h n	8
acute otitis media in	8
seasonal influenza vaccination in	8
a dna vaccine induces	8
were found in the	8
for the construction of	8
specific memory t cells	8
it was found that	8
immunogenicity and safety of	8
recommendations of the advisory	8
have been associated with	8
cause of severe acute	8
the viral load in	8
hepatitis b surface antigen	8
utr of s tr	8
identification of a novel	8
cervical lymph node cells	8
hong kong and singapore	8
were randomly divided into	8
to a lesser extent	8
to develop a vaccine	8
data to this article	8
is a member of	8
the cd t cell	8
the efficacy of the	8
of modified vaccinia virus	8
were used for the	8
venezuelan equine encephalitis virus	8
to evaluate the efficacy	8
standardized template with key	8
advisory group of experts	8
strategic advisory group of	8
the nucleocapsid protein of	8
of the vaccine was	7
in the us and	7
collaboration viral vector vaccines	7
would be willing to	7
as a vaccine vector	7
number of cases of	7
for h at rt	7
humoral immune responses in	7
this is the first	7
vlps and inactivated h	7
periods with elevated activity	7
mucosal as well as	7
during the observation period	7
disease burden of influenza	7
as one of the	7
were significantly higher than	7
in the spike protein	7
the spread of the	7
there was no significant	7
antibodies against rsv subgroup	7
immunogenicity of a recombinant	7
disease prevention and control	7
classical swine fever virus	7
been found to be	7
siv uptake among hcp	7
and to a lesser	7
and mvaik rsv f	7
syndrome coronavirus spike glycoprotein	7
of the disease in	7
protection against myxomatosis and	7
and protective immunity in	7
for the production of	7
willingness to pay for	7
was associated with a	7
and is expected to	7
as described in section	7
towards the human mhc	7
of influenza and rsv	7
total rna was extracted	7
specific cd and cd	7
the activation of the	7
west nile virus encephalitis	7
in any of the	7
mhc class i molecules	7
horizontal transmissible protection against	7
of primary health care	7
embryonated spf chicken eggs	7
efficacy and effectiveness of	7
is based on the	7
c mice were immunised	7
cd t cells was	7
vesicular stomatitis virus vectors	7
in the sera of	7
on day of age	7
by the use of	7
divided into four groups	7
the vertical coordinate is	7
to the fact that	7
dna vaccine induces sars	7
under the control of	7
the purpose of this	7
the neutralizing antibody titer	7
cats of the placebo	7
humoral and cellular immunity	7
the rn protein formulated	7
immune responses in mice	7
herpes simplex virus type	7
respiratory syncytial virus disease	7
pediatric health center patients	7
protection against challenge with	7
the general adult population	7
of health of the	7
comparable to that of	7
were approved by the	7
the fusion ability of	7
was similar to that	7
health center patient survey	7
washed three times with	7
to better understand the	7
be included in the	7
the time of vaccination	7
of the working group	7
of the recombinant virus	7
were challenged with sars	7
the modified live virus	7
the health center patient	7
plates were incubated for	7
of morbidity and mortality	7
as well as for	7
on the cell surface	7
the course of the	7
than that in the	7
humoral immune response to	7
of influenza vaccination in	7
the sequence of the	7
on days and post	7
to each well and	7
seasonal and pandemic influenza	7
will need to be	7
trivalent inactivated influenza vaccine	7
as evidenced by the	7
recombinant modified vaccinia virus	7
brighton collaboration viral vector	7
spike protein is a	7
west nile virus vaccine	7
were considered to be	7
significantly higher than that	7
analysis was carried out	7
of the virus to	7
in the early s	7
d s d ns	7
efficacy of the vaccine	7
induces sars coronavirus neutralization	7
increase in probability of	7
neutralization and protective immunity	7
of vaccines and vaccination	7
the s gene of	7
of canine parvovirus type	7
specific cytotoxic t lymphocytes	7
viral load in the	7
the brighton collaboration viral	7
by the end of	7
the development of new	7
attributes and attribute levels	7
sars coronavirus neutralization and	7
animal and human health	7
may contribute to the	7
of the vaccine and	7
vaccine induces sars coronavirus	7
against lethal challenge with	7
is likely to be	7
at a dilution of	7
at the beginning of	7
a high level of	7
as part of a	7
an increased frequency of	7
by the favn assay	7
multimethods study in england	7
in a cohort of	7
was shown to be	7
the cost of the	7
cellular immune responses in	7
immunization of mice with	7
a multimethods study in	7
the morbidity and mortality	7
in each group were	7
presence or absence of	7
not necessarily represent the	7
significantly lower than the	7
the viruses and their	7
the use of vaccines	7
also observed in the	7
were used to evaluate	7
risk of enhanced disease	7
no conflict of interest	7
plates were incubated at	7
and the expression of	7
data were analyzed using	7
the s protein of	7
at different time points	7
nm nm nm nm	7
vector is replication incompetent	7
of the last years	7
at position of the	7
has been shown that	7
for the control of	7
analyses were performed using	7
viruses and their replication	7
g ha influenza a	7
of a live attenuated	7
were collected from the	7
the protective effect of	7
coronavirus neutralization and protective	7
transmissible protection against myxomatosis	7
both cd and cd	7
was significantly lower than	7
than years of age	7
the safety of the	7
detected in the trachea	7
the objective of this	7
the coalition for epidemic	7
antibody levels in the	7
these data suggest that	7
reciprocal of the highest	7
pneumonia in older adults	7
in adolescents and adults	7
pandemic influenza a h	7
in the immunization group	7
influenza vaccination coverage among	7
for respiratory syncytial virus	7
with the use of	7
incubated at room temperature	7
test was used to	7
a pool of sars	7
and immunogenicity of an	7
in the faeces of	7
previously been shown to	7
with the potential to	7
valent pneumococcal polysaccharide vaccine	7
results of this study	7
on the role of	7
the use of a	7
ch lhlj v strain	7
h n vaccine in	7
ministry of health of	7
the h n pandemic	7
from animals to humans	7
in infants and children	7
with rsv subgroup a	7
protein expression in mammalian	7
our results show that	7
the innate immune response	7
the global vaccine action	7
analysis was performed using	7
in this study were	7
g for min and	7
a discrete choice experiment	7
infectious bronchitis virus and	7
influenza and respiratory syncytial	7
in this age group	7
for the treatment of	6
neutralising antibodies and cellular	6
the results of a	6
the presence of sars	6
with a lethal dose	6
the presence of co	6
or mvaik rsv g	6
divided into three groups	6
to determine if the	6
vaccine and placebo group	6
of the effects of	6
region i and region	6
protective immune responses against	6
the humoral immune response	6
the purified inactivated sars	6
immune response to the	6
effectiveness of inactivated influenza	6
approved by the institutional	6
an animal model for	6
avf full s mf	6
of the virus suspension	6
samples were from dogs	6
the horizontal coordinate is	6
of a modified live	6
differences were observed between	6
and kidney samples were	6
the time of the	6
included in the study	6
herds b and c	6
prevention and control of	6
and assessed for ciliary	6
mlv mtb wcl vaccinated	6
response to influenza vaccination	6
expressed by attenuated vaccinia	6
inactivation of viral antigens	6
the institutional animal care	6
mice were immunized with	6
old balb c mice	6
plates were coated with	6
for the h n	6
which have been shown	6
s d ns ratio	6
a broad range of	6
to reject a covid	6
bse or eda ese	6
this study was supported	6
red blood cells in	6
of high levels of	6
cells were fixed with	6
the development of an	6
ad vector is replication	6
these results indicate that	6
that there was a	6
by the university of	6
of the s gene	6
antibodies and cellular immune	6
of the virus in	6
may be associated with	6
rift valley fever vaccines	6
removed and assessed for	6
wild type virus from	6
a high binding affinity	6
have been tested in	6
considered as potential competing	6
after the first immunization	6
was not detected in	6
morbidity and mortality in	6
the highest dilution of	6
was significantly higher than	6
human and veterinary medicine	6
of the innate immune	6
at and years post	6
of a vaccine for	6
room temperature for min	6
the large number of	6
error of the mean	6
of one or more	6
epitopes of the n	6
in the face of	6
were washed three times	6
the s subunit of	6
a t h response	6
and cp influenza viruses	6
the next influenza pandemic	6
institute for biological standards	6
the h vaccine strain	6
in the long term	6
may be considered as	6
of five mice were	6
number of studies have	6
by the presence of	6
vaccine candidates against mers	6
in the late s	6
rsv g and f	6
coronavirus avian infectious bronchitis	6
each group were euthanized	6
in accordance with the	6
study was supported by	6
the rh and rh	6
the following financial interests	6
passage in embryonated eggs	6
the effects of the	6
of the highest dilution	6
is the most important	6
as potential competing interests	6
evaluate the efficacy of	6
as well as to	6
that the spike protein	6
pigs inoculated with prrs	6
sequence analysis of the	6
was not observed in	6
following financial interests personal	6
was lower than that	6
a broad spectrum of	6
were determined to be	6
the aim of this	6
lower than that of	6
the adjuvant effect of	6
trachea and kidney samples	6
the rift valley fever	6
were used in the	6
of human and animal	6
mlv mtb wcl inoculated	6
the nw adherent fraction	6
likely to reject a	6
there was no difference	6
personal relationships which may	6
was funded by the	6
enhancement of lactogenic immunity	6
authors declare the following	6
was also observed in	6
the introduction of the	6
in the preparation of	6
against a variety of	6
against middle east respiratory	6
the central nervous system	6
kindly provided by dr	6
vaccinated and control calves	6
fragment of p tl	6
samples were collected at	6
at room temperature and	6
can also be used	6
and mortality in the	6
that received gb and	6
acceptance of a covid	6
group was immunized with	6
bureau of primary health	6
a systematic review of	6
for use in the	6
which has been shown	6
standard error of the	6
with the help of	6
confirmed influenza pneumonia in	6
the expression of the	6
the causative agent of	6
and the role of	6
infectious bronchitis virus vaccines	6
of seasonal influenza vaccination	6
were shown to be	6
and stored in aliquots	6
chickens infected with the	6
haemophilus influenzae type b	6
determinant of cell tropism	6
binding domain of mers	6
recombinant swinepox virus expressing	6
serum vn antibody levels	6
the impact of influenza	6
have been reported in	6
infectious bronchitis virus isolates	6
the pulmonary viral titer	6
the yellow fever vaccine	6
and the vertical coordinate	6
the middle east respiratory	6
with the spike protein	6
there were no significant	6
levels of neutralizing antibody	6
calves in herd b	6
challenge with the virulent	6
be noted that the	6
declare the following financial	6
fraction between and sucrose	6
effectiveness of influenza vaccines	6
the h n influenza	6
financial interests personal relationships	6
the disease burden of	6
by polymerase chain reaction	6
have not yet been	6
the identification of the	6
syncytial virus infection in	6
on the day of	6
and the frequency of	6
we were unable to	6
for the use of	6
is based on a	6
cut fragment of p	6
these data demonstrate that	6
induction of protective immunity	6
with any of the	6
it is hoped that	6
can be used as	6
a high proportion of	6
the need for a	6
against rift valley fever	6
infectious bronchitis virus vaccine	6
chicks from each group	6
in a co incubator	6
that in the control	6
ep and cp influenza	6
results indicate that the	6
studies are needed to	6
assessed for ciliary activity	6
simple method of estimating	6
number of tests performed	6
referred to in the	6
occurred between p and	6
with g ml of	6
with that of the	6
type virus from which	6
in probability of vaccine	6
and the risk of	6
in the template as	6
in order to determine	6
were carried out in	6
mtb wcl vaccinated pigs	6
efficacy and safety of	6
an increased risk of	6
were challenged with pfu	6
the respiratory tract and	6
influenza vaccination in older	6
groups of five mice	6
which may be considered	6
and the presence of	6
the host response to	6
recombinant measles viruses expressing	6
be explained by the	6
in the vaccine and	6
be associated with the	6
national institute for biological	6
to be used as	6
has the ability to	6
their tracheas removed and	6
in the prevention of	6
a phase i ii	6
infectious virus was recovered	6
not heard of h	6
infectious bronchitis virus the	6
were found to contain	6
of colleagues intending to	6
viral respiratory infections in	6
the n protein of	6
interests personal relationships which	6
is possible that the	6
acute viral respiratory infections	6
the concentration of the	6
at weeks of age	6
by attenuated vaccinia virus	6
of the vaccine group	6
diarrhoea and mortality in	6
intention to get vaccinated	6
with pfu of pr	6
enhanced respiratory syncytial virus	6
of newcastle disease virus	6
groups b and c	6
similar to those of	6
i i i i	6
with a pool of	6
for other respiratory viruses	6
preventable diseases in the	6
these results suggest that	6
pcr assay for the	6
mvaik rsv g and	6
as well as in	6
cats of the vaccine	6
of the viral vector	6
have been identified in	6
and should not be	6
after serial passages in	6
method of estimating fifty	6
of age or older	6
old spf chickens were	6
used as a negative	6
immune responses against sars	6
of avian influenza a	6
development and use of	6
we have demonstrated that	6
the average number of	6
in infants and young	6
respiratory tract infections in	6
convenience in access to	6
in comparison to the	6
is significantly higher than	6
have shown that a	6
evaluate the safety and	6
a final concentration of	6
transmissible gastroenteritis virus and	6
development and evaluation of	6
the context of a	6
t cells in the	6
vaccine safety and immunogenicity	6
the s and s	6
of the cattery cats	6
of age and older	6
in the last years	6
i and region ii	6
to be involved in	6
m and g proteins	6
the risk of enhanced	6
supplemented with fetal bovine	6
cd t cells and	6
of influenza vaccine in	6
purpose of this study	6
and cellular immune response	6
be used as an	6
the difference between the	6
mtb wcl inoculated pigs	6
in the experimental group	6
participate in a clinical	6
cellular immune responses against	6
the day vaccination group	6
relationships which may be	6
both cellular and humoral	6
to days of age	6
diseases in the united	6
followed by incubation with	6
be considered as potential	6
challenged with pfu of	6
years of age and	6
and a number of	6
had not heard of	6
the vector and vaccine	6
of t cell responses	6
to the production of	6
to in the template	6
neutralizing antibody titers in	6
is important to understand	6
tracheas removed and assessed	6
a simple method of	6
the cervical lymph node	6
these data indicate that	6
dengue virus capsid protein	6
in the vaccine group	6
at a final concentration	6
to vaccinate their children	6
to influenza virus infection	5
who had heard of	5
it can be seen	5
for severe acute respiratory	5
protein expressed by attenuated	5
of porcine epidemic diarrhea	5
was defined as the	5
a critical role in	5
protection against lethal challenge	5
were also found to	5
data from a phase	5
increase in vaccine efficacy	5
the titre and duration	5
and immunogenicity of novel	5
a single injection of	5
after the prime immunization	5
transcriptase polymerase chain reaction	5
against rsv subgroup b	5
were inoculated by i	5
areas of the world	5
the importance of the	5
the host immune system	5
had heard of h	5
of recombinant vaccinia viruses	5
of transmissible gastroenteritis virus	5
was not statistically significant	5
of the vaccinated mice	5
and modified vaccinia ankara	5
in the s with	5
s sequencing qx s	5
one week after the	5
at days of age	5
a lethal dose of	5
as shown in the	5
cells in the presence	5
was used to analyze	5
in africa and asia	5
of the cervical lymph	5
mouth disease in the	5
and services administration bureau	5
serum samples were serially	5
and the level of	5
formulated in isa cpg	5
vaccines targeting the nucleocapsid	5
the rest of the	5
after immunization with mvaik	5
of the spike gene	5
risk of reversion to	5
high titers of neutralizing	5
coronavirus in patients with	5
is shown in fig	5
protein is responsible for	5
against infectious bronchitis virus	5
is illustrated in fig	5
added to the wells	5
of acute phase proteins	5
biologics evaluation and research	5
a high degree of	5
myxomatosis and rabbit haemorrhagic	5
immune responses against a	5
to be vaccinated against	5
respiratory syndrome coronavirus as	5
a live virus vaccine	5
of the recombinant protein	5
weeks of age and	5
mhc class i molecule	5
a novel coronavirus from	5
in the nw adherent	5
have been due to	5
were not included in	5
cotton rats were immunized	5
low and middle income	5
between the two groups	5
carried out as described	5
open reading frame of	5
llv in the absence	5
for a total of	5
we have shown that	5
or in combination with	5
adjuvanticity of mtb wcl	5
do not necessarily represent	5
in relation to the	5
generation and characterization of	5
by porcine reproductive and	5
protective efficacy of a	5
both ep and cp	5
rsv f or mvaik	5
during the period of	5
in an endemic area	5
in mice and hamsters	5
at days after the	5
respiratory syncytial virus in	5
in the trachea of	5
the highest antibody response	5
when the vaccine was	5
in the treatment group	5
by the institutional animal	5
of experts on immunization	5
tr protein expression in	5
to the emergence of	5
protein is a determinant	5
possible cause of severe	5
the high incidence of	5
for the diagnosis of	5
and risk factors for	5
with the aim of	5
significantly higher than the	5
viral rna was extracted	5
a review of the	5
correlated well with the	5
in more than one	5
to be associated with	5
that can serve as	5
australia and new zealand	5
cells were used as	5
positive for other respiratory	5
calculated according to the	5
advances in the development	5
and rabbit haemorrhagic disease	5
of the dengue virus	5
in the trachea and	5
vsvs with mutated m	5
characterization of dna vaccines	5
was higher in the	5
in a short period	5
was determined to be	5
have shown that the	5
more than of the	5
no infectious virus was	5
as cd and cd	5
as a possible cause	5
the secretion of il	5
were found to have	5
the gene encoding the	5
used to analyze differences	5
in each of the	5
a h n and	5
to induce protective immunity	5
the influenza and rsv	5
reaction was stopped with	5
the upper and lower	5
with hepatitis b vaccine	5
of the virus and	5
potential safety issues and	5
product development for vaccines	5
the plates were washed	5
belonging to the high	5
the ive against influenza	5
of the number of	5
no significant differences in	5
did not show any	5
of foxes against rabies	5
willing to accept a	5
from mice immunized with	5
in week compared to	5
was based on a	5
c mice were immunized	5
randomly divided into four	5
arabia middle east respiratory	5
be detected in the	5
dose of chadox mers	5
with the results of	5
of dna vaccines targeting	5
in the trachea at	5
in the elderly and	5
sac ii and pac	5
by a combination of	5
and characterization of dna	5
were washed twice with	5
modified live tgev vaccine	5
this is consistent with	5
cellular and humoral immunity	5
were also observed in	5
end of the second	5
cells were detected in	5
the immunogenicity of a	5
aids research reference reagent	5
we were able to	5
acute respiratory syndrome in	5
in this study was	5
development for vaccines advisory	5
a recombinant vesicular stomatitis	5
the leading cause of	5
canada and the usa	5
as determined by the	5
the availability of a	5
for biologics evaluation and	5
access to health care	5
from each of the	5
the youngest age groups	5
influenza pneumonia in older	5
is associated with a	5
the biology of the	5
immune responses in humans	5
in order to avoid	5
based on these results	5
expanded programme on immunizations	5
to the presence of	5
the s tr protein	5
s gene of the	5
and middle income countries	5
and modified vaccinia virus	5
a h n vaccine	5
the lack of a	5
the cervical lymph nodes	5
the use of an	5
aspects of vaccines and	5
transmissible gastroenteritis of swine	5
to the use of	5
were subtracted from the	5
by the fact that	5
of bcg and m	5
safe and effective vaccine	5
it has also been	5
a significant reduction in	5
to participate in the	5
demonstrates that the spike	5
rn protein formulated with	5
to the poultry industry	5
in this study is	5
for biological standards and	5
was first isolated in	5
the genome of the	5
in the past years	5
did not alter the	5
dilution of the original	5
were challenged with ml	5
can serve as a	5
recombinant vaccinia virus expressing	5
sera were collected from	5
a period of days	5
services administration bureau of	5
be used for the	5
of neutralizing antibodies against	5
responses against sars coronavirus	5
stomatitis virus vectors expressing	5
compared with that of	5
in the lungs and	5
this approach has been	5
in the small intestine	5
with field strains of	5
samples were serially diluted	5
it is not clear	5
cells were maintained in	5
the lungs of prrs	5
takes into account the	5
results showed that the	5
t cell responses to	5
well as for the	5
five trachea and kidney	5
nih aids research reference	5
by a single immunization	5
the authors would like	5
in the group that	5
the ministry of health	5
has been demonstrated that	5
for the generation of	5
of pandemic influenza a	5
results are shown in	5
a concomitant reduction in	5
a number of different	5
the young pet cats	5
responses and protection against	5
of simian immunodeficiency virus	5
should not be construed	5
the placebo group died	5
the us and eu	5
risk of disease enhancement	5
and shown to be	5
ml recombinant human interleukin	5
a global public health	5
a possible cause of	5
bill melinda gates foundation	5
are in agreement with	5
carried out using the	5
in this study we	5
were collected and the	5
among health center patients	5
the frequency of tregs	5
sensitivity and specificity of	5
indian alaska native children	5
can be used in	5
diagnosis of viral diseases	5
serial dilutions of the	5
more prone to get	5
in the sedimentable particles	5
morbidity and mortality were	5
vaccine candidates have been	5
a neutralizing antibody response	5
as a vector for	5
with the development of	5
the s protein was	5
vivo and in vitro	5
of the sars coronavirus	5
to those induced by	5
studies a and b	5
in an attempt to	5
ch lhlj v p	5
to influenza vaccination in	5
the first time in	5
with pfu of vp	5
the generation of new	5
in the placebo group	5
the number of prescriptions	5
by a number of	5
obtained from the national	5
studies c and d	5
group of experts on	5
in animals and humans	5
t cell responses were	5
of subjects in the	5
and weeks of age	5
the vast majority of	5
antibodies against sars cov	5
in specific pathogen free	5
in spite of the	5
the avian coronavirus infectious	5
of the most cost	5
pigs vaccinated intranasally with	5
vaccination with a recombinant	5
of a new vaccine	5
way analysis of variance	5
it has been demonstrated	5
bovine parainfluenza virus type	5
it is well known	5
between region i and	5
these results demonstrate that	5
have been developed by	5
coronavirus as a possible	5
spike protein expressed by	5
for the majority of	5
were expressed as the	5
than those in the	5
fold higher than the	5
and incubated for min	5
role of complement in	5
were vaccinated with the	5
such as cd and	5
and efficacy of an	5
vaccine research and development	5
the united states during	5
morbidity and mortality for	5
the protection afforded by	5
of the development of	5
on day of the	5
mouth disease virus leader	5
single dose of chadox	5
the cotton rats immunized	5
professional antigen presenting cells	5
immunogenicity of an inactivated	5
plaque reduction neutralization test	5
in the levels of	5
of a h n	5
of the human immunodeficiency	5
saudi arabia middle east	5
of neutralizing antibodies and	5
phase i clinical trial	5
in cd t cells	5
with ml of the	5
did not result in	5
frequency of nk cells	5
producing cd and cd	5
using the pseudotype assay	5
targeting the nucleocapsid protein	5
respiratory syndrome coronavirus vaccine	5
nephropathogenic infectious bronchitis virus	5
after the last immunization	5
and there is no	5
epitopes in severe acute	5
could be used as	5
i ifn signaling competent	5
to the pbs control	5
infection in dromedary camels	5
who had not heard	5
viral load and vaccine	5
of the m spike	5
global action plan for	5
it may be possible	5
n and n peptides	5
mucosal and systemic immunity	5
induce high levels of	5
fusion ability of the	5
plays a role in	5
of purified inactivated sars	5
one or more of	5
in all age groups	5
after the viral challenge	5
to a h n	5
and the control group	5
for the preparation of	5
against rsv subgroups a	5
similar results were obtained	5
the rational design of	5
maturation of dendritic cells	5
were examined daily for	5
responses in mice immunized	5
mtb wcl compared to	5
the need for standardized	5
immune responses to a	5
encoding the s protein	5
associated coronavirus vaccine in	5
between vaccinated and control	5
the number of cases	5
australian and new zealand	5
and newcastle disease virus	5
respiratory syndrome coronavirus in	5
of a number of	5
vaccinated intranasally with prrs	5
dna vaccines targeting the	5
oie positive control serum	5
of p and p	5
to be the most	5
prone to get vaccinated	5
significantly higher in the	5
of influenza a virus	5
center for biologics evaluation	5
accept to participate in	5
a recombinant vaccinia virus	5
attenuated vsvs with mutated	5
not included in the	5
is believed to be	5
may be possible to	5
for h at c	5
development of vaccines for	5
and the number of	5
strain of infectious bronchitis	5
by the development of	5
to global public health	5
the day and groups	5
to determine whether the	5
a h n influenza	5
the absence of any	5
as well as systemic	5
be willing to accept	5
of mtb wcl to	5
as a source of	5
infectious bronchitis virus field	5
the characteristics of the	5
a epitope of the	5
serum samples were collected	5
groups were not statistically	5
specific igg and igg	5
t cell responses against	5
of reversion to virulence	5
ii and pac i	5
lower respiratory tract infections	5
virus protectively immunizes mice	5
of a safe and	5
compared to the non	5
in the stimulation of	5
in order to evaluate	5
influenza and other respiratory	5
has been proven to	5
was a significant increase	5
the developing countries vaccine	5
vaccines based on a	5
for vaccines advisory committee	5
the efficacy of this	5
to ensure that the	5
by the v swg	5
the neutralization titer of	5
the mice immunized with	5
daily for clinical signs	5
against rsv subgroup a	5
vaccine based on the	5
does an animal model	5
ark pathogenic field virus	5
authors would like to	5
sequence of the sars	5
p and p were	5
is likely that the	5
as described in fig	5
to severe acute respiratory	5
between the vaccine and	5
during the course of	5
crystal structure of the	5
for the detection and	5
by the world health	5
in animals vaccinated with	5
a comparison of the	5
used as a positive	5
influenza a or b	5
with a decrease in	5
influenza vaccine effectiveness in	5
mo or lc m	5
the first week of	5
coronavirus spike protein expressed	5
administration bureau of primary	5
novel coronavirus in patients	5
immune correlates of protection	5
the titers of the	5
vaccine in healthy adults	5
in the level of	5
the context of the	5
as the number of	5
for disease prevention and	5
vaccinia virus protectively immunizes	5
attenuated vaccinia virus protectively	5
at the university of	5
the presence or absence	5
with a concomitant reduction	5
the extent to which	5
influenza h n virus	5
titre and duration of	5
lc mo or lc	5
kidney samples were collected	5
in the event of	5
strains were detected in	5
for the purposes of	5
years of age or	5
in the s protein	5
for a period of	5
of ck ch lhlj	5
supernatants were collected and	5
vaccination in older adults	5
a small number of	5
the ratio of the	5
cells were stimulated with	5
on influenza vaccine effectiveness	5
dpv serum from swine	5
cells from lymph nodes	5
in response to alvac	5
week after the last	5
was responsible for the	5
based vaccines have been	5
influenza vaccine in the	5
porcine transmissible gastroenteritis virus	5
are presented in fig	5
be involved in the	5
is due to the	5
h n pandemic influenza	5
the etiological agent of	5
specific t cell responses	5
received gb and alvac	5
a novel coronavirus in	5
with respiratory syncytial virus	5
both systemic and mucosal	5
oral and cloacal swabs	5
pfu ml in ml	5
neutralizing antibodies against the	5
the m spike protein	5
due to the different	5
g for min at	5
and evaluation of a	5
vaccination of mice with	5
and then challenged with	5
mhc class i and	5
remains one of the	5
of human dendritic cells	5
in a recent study	5
nucleocapsid protein of severe	5
at the injection site	5
the oie positive control	5
the impact of vaccination	5
is the most common	5
as long as the	5
g or vsv m	5
research is needed to	5
cells were transfected with	5
immunization with mvaik rsv	5
patient information leaflet languages	5
to transmissible gastroenteritis virus	5
a public health emergency	5
factors related to vaccine	5
over years of age	5
neutralizing antibody titer was	5
day after the prime	5
was used for the	5
have been developed and	5
of ibv ck ch	5
in saudi arabia middle	5
in the arkga p	5
may be attributed to	5
it is worth noting	5
research reference reagent program	5
f or mvaik rsv	5
vaccinated with arkga p	5
spike protein of the	5
can be achieved by	5
of a sars vaccine	5
it is interesting to	5
did not differ significantly	5
and the extent of	5
the nature of the	5
the infectious bronchitis virus	5
it is apparent that	5
balance between pathogenesis and	5
with a potent adjuvant	5
and the plates were	5
and b malaysia virus	5
mice immunized with vaccine	5
ethical aspects of vaccines	5
influenza and rsv periods	5
the absence of a	5
nw adherent fraction of	5
the most likely cluster	5
of the influenza virus	5
of the safety and	5
mvaik rsv f or	5
in the s region	5
development of a recombinant	5
of viral replication and	5
the quality of the	5
of the structural proteins	4
h n vaccine with	4
subtracted from the respective	4
with placebo or alvac	4
was used in a	4
of immune responses to	4
taking advantage of the	4
the health resources and	4
is caused by the	4
between the vector and	4
of the efficacy of	4
biology and pathogenesis of	4
infectious peritonitis virus infection	4
one calf was excluded	4
first few weeks of	4
vaccinated with the rh	4
observed in the lungs	4
proportion of colleagues intending	4
like to thank drs	4
m and or g	4
is the case for	4
it has been suggested	4
that is able to	4
mtb wcl was detected	4
a multiplicity of infection	4
the chicks were examined	4
the properties of the	4
inoculated eggs were incubated	4
shown to be a	4
infectious bronchitis virus from	4
vertical coordinate is the	4
that there may be	4
for shedding and transmission	4
is thought to be	4
human factors related to	4
rna virus belonging to	4
for min and the	4
beef herds in argentina	4
and the cells were	4
spike protein of sars	4
stored in aliquots at	4
presentation of vaccine safety	4
the genetic stability of	4
rsv g and pmvaik	4
in c bl mice	4
monkeys were challenged with	4
immunogenicity of modified vaccinia	4
was eluted from the	4
respiratory syncytial virus and	4
the respiratory tracts of	4
e and m proteins	4
are expressed as the	4
of years and older	4
icmje criteria for authorship	4
west nile virus envelope	4
plan for influenza vaccines	4
the purified sars vaccine	4
observed daily for clinical	4
as a vaccine candidate	4
compared to vaccine alone	4
no significant differences were	4
a heterologous ebola vaccination	4
and immunogenicity of recombinant	4
fold serial dilutions of	4
and the amount of	4
chickens were divided into	4
the viral structural proteins	4
related to vaccine acceptance	4
high levels of sars	4
to be effective in	4
the pathogenic m strain	4
by the pseudotype assay	4
analyzed by western blotting	4
increase the number of	4
were provided ad libitum	4
to be an effective	4
ideal balance between pathogenesis	4
of a modified vaccinia	4
in human and veterinary	4
after the third vaccination	4
months of age and	4
pig red blood cells	4
inactivated sars vaccine was	4
the uk vaccine network	4
science of vaccine safety	4
considered to be significant	4
with infectious bronchitis virus	4
a simple strategy for	4
immunized with different doses	4
vaccine safety and efficacy	4
in guangzhou and hong	4
participate in the study	4
vaccinated and challenged group	4
produced in response to	4
in the treatment of	4
sera were collected and	4
position of the p	4
it was shown that	4
outbreak in west africa	4
assay was carried out	4
the seasonal influenza vaccine	4
allantoic fluid was harvested	4
before the onset of	4
at the top of	4
vaccine in infants and	4
both of which have	4
any agency determination or	4
the cd t cells	4
increased the frequency of	4
between vector and vaccine	4
from a phase randomized	4
no statistically significant difference	4
ive against influenza pneumonia	4
humans or other species	4
during periods with elevated	4
produced in insect cells	4
not be construed to	4
they meet the icmje	4
protein gene of the	4
by one way anova	4
infectious cdna clone of	4
detection and identification of	4
of the vaccine strain	4
p whole genome sequence	4
was determined by the	4
for at least days	4
associated with acute respiratory	4
the a epitope of	4
the severity of the	4
was carried out to	4
have also been shown	4
the induction of the	4
from which the vector	4
of lc m in	4
of mhc class i	4
brome mosaic virus rna	4
opens at lunch time	4
reviewed and approved by	4
in the field of	4
to that induced by	4
for collection of key	4
calves in herd a	4
with a titer of	4
in a final volume	4
challenged with rsv subgroup	4
as belonging to the	4
published by elsevier ltd	4
data indicate that the	4
the risk of reversion	4
were excluded from the	4
the clinical signs of	4
of rotavirus and coronavirus	4
acute respiratory syndrome sars	4
the effect of the	4
a vesicular stomatitis virus	4
herds a and b	4
and cervical lymph node	4
specific humoral and cellular	4
to accept h n	4
of approximately log x	4
porcine respiratory coronavirus in	4
of influenza a h	4
with mutated m and	4
studies have suggested that	4
to be used for	4
is an example of	4
for standardized case definitions	4
for the duration of	4
no significant differences between	4
to the wells and	4
post auricular and cervical	4
singly or in combination	4
antibody response in mice	4
used to estimate the	4
a and b viruses	4
and the results of	4
of inactivated influenza vaccine	4
immune response to vaccination	4
titres in mammary secretions	4
of tregs in the	4
use in older adults	4
our results indicate that	4
preference for influenza vaccination	4
capable of inducing neutralizing	4
clinical strains of mers	4
neutralizing antibodies in mice	4
vaccine candidates are in	4
also be used to	4
neutralizing antibody titers of	4
on the type of	4
antibodies in the sera	4
influenza vaccine uptake among	4
and lower respiratory tract	4
afraid of being infected	4
with or without tpa	4
favn and pseudotype assays	4
analysis and presentation of	4
the different age groups	4
in the activation of	4
of s tr protein	4
in the day and	4
the vector organism is	4
the potential impact of	4
recombinant vsvs expressing the	4
of vaccine safety data	4
effects of a sars	4
against severe acute respiratory	4
were calculated as the	4
the cattery cats and	4
with sterile allantoic fluid	4
acute respiratory syndrome characterization	4
are significantly associated with	4
the first time that	4
mice were sacrificed at	4
infected with passage virus	4
ch lhlj v passages	4
a transgenic mouse model	4
mice were sacrificed and	4
was as low as	4
membrane was incubated with	4
for a number of	4
be construed to represent	4
sequence analysis and comparison	4
first year of life	4
transfected hek t cells	4
play a more important	4
the challenges associated with	4
gene demonstrates that the	4
and mva based vaccine	4
c b and c	4
in response to a	4
respiratory syndrome is associated	4
acute respiratory distress syndrome	4
are presented in table	4
measles vaccine expressing the	4
due to the high	4
for the application of	4
days prior to farrowing	4
in the fight against	4
group that received the	4
could be due to	4
respiratory syndrome coronavirus infections	4
of the most important	4
with the ribyz strain	4
prevention and treatment of	4
which the vector is	4
in the cotton rats	4
calf was excluded because	4
of the human dose	4
was no difference in	4
a short period of	4
a great deal of	4
due to the low	4
is the cause of	4
restricted cd t cell	4
has also been demonstrated	4
is estimated to be	4
a variety of viral	4
elisa plates were coated	4
animals as a means	4
as an alternative to	4
the membrane was incubated	4
h n vaccine and	4
health care workers in	4
the ep and cp	4
it is known that	4
safe and effective vaccines	4
influenza and rsv activity	4
veterinary and human medicine	4
isolation and characterization of	4
to the best of	4
a severe acute respiratory	4
to that of a	4
and immunogenicity of modified	4
was measured using a	4
the simultaneous detection of	4
associated with a decrease	4
for their contribution to	4
pandemic influenza vaccine in	4
the safety and characteristics	4
live virus vaccines based	4
it is important that	4
the beaudette spike protein	4
chemokines cxcl and ccl	4
t cells was detected	4
immunity between vector and	4
rabbits were observed daily	4
vaccine was used in	4
the modified live tgev	4
than the pbs group	4
due to the lack	4
and serum samples were	4
by the introduction of	4
were used in this	4
the possibility of developing	4
affinity towards the human	4
also opens at lunch	4
of the general adult	4
the cells were washed	4
mice that received gb	4
heterologous ebola vaccination regimen	4
not significantly different from	4
the population of the	4
have been demonstrated to	4
spf chickens were divided	4
birds from each group	4
were based on the	4
to respiratory syncytial virus	4
for the total population	4
in human cells and	4
have also been reported	4
was kindly provided by	4
the induction of a	4
amino acid substitutions in	4
cytotoxic t lymphocytes and	4
frequency of th cells	4
acute respiratory tract infections	4
was added and incubated	4
in some of the	4
proportion of tests positive	4
research and development of	4
the international council for	4
protein of infectious bronchitis	4
occurred in the s	4
advisory committee on vaccine	4
of the attenuated virus	4
and systemic immune responses	4
that can be used	4
a statistically significant level	4
the local draining lymph	4
immunopathology on challenge with	4
two doses of mva	4
frequency of h n	4
in commercial broiler chicks	4
passaged in vero cells	4
for each of the	4
expressing a heterologous spike	4
and incubated overnight at	4
the structural proteins of	4
neutralizing antibody titers were	4
were used at a	4
was performed with the	4
control calves in herd	4
can be concluded that	4
sars cov n protein	4
be used to prevent	4
at the level of	4
the intention to get	4
of african swine fever	4
mhc class i pathway	4
with truncated g protein	4
among american indian alaska	4
found to be safe	4
sequence changes in the	4
of avian coronavirus ibv	4
source of infection of	4
a phase randomized clinical	4
was calculated according to	4
candidates are in development	4
reminded the audience that	4
to the sars coronavirus	4
the first year of	4
alvac can act as	4
before and after the	4
what will be the	4
proteins of severe acute	4
the basis of the	4
among healthcare workers in	4
it may be that	4
coronavirus vaccine in monkeys	4
to represent any agency	4
both g and m	4
significant difference in the	4
vaccination was associated with	4
in the st century	4
of mycobacterium tuberculosis induces	4
c for h and	4
in vivo rna stability	4
the brighton collaboration standardized	4
of the national institutes	4
week old female balb	4
auricular and cervical lymph	4
evaluating candidate sars vaccines	4
to the surface of	4
london school of hygiene	4
gave the highest antibody	4
found to be comparable	4
the prevention of sars	4
sars s dna vaccine	4
of red blood cells	4
at weeks post hatch	4
and th immune responses	4
the endogenous f promoter	4
n pandemic influenza vaccine	4
presented as the mean	4
with modified vaccinia virus	4
the induction of protective	4
of the centers for	4
for each age group	4
at the first visit	4
the pathogenicity of the	4
were inoculated intranasally with	4
vaccine in balb c	4
with a focus on	4
a total volume of	4
was consistent with the	4
and or g proteins	4
the efficacy and safety	4
water were provided ad	4
chicken red blood cells	4
expressing the wnv e	4
was used to estimate	4
the difference of the	4
in animal models and	4
significant differences were observed	4
virus as a vaccine	4
assessment of the covid	4
water and stored at	4
the control group in	4
present on the surface	4
human and camel mers	4
of acellular pertussis vaccines	4
children with influenza b	4
expressed in hek t	4
and mortality in calves	4
and were challenged with	4
animals vaccinated with bei	4
is similar to the	4
the volume of the	4
mice were immunized i	4
i and type ii	4
p and p showed	4
agency determination or policy	4
as compared to the	4
mucosal and systemic immune	4
gastroenteritis virus and porcine	4
c in a co	4
associated with a higher	4
th of the human	4
lineage of influenza b	4
in the cervical lymph	4
the center for biologics	4
and presentation of vaccine	4
were divided into three	4
the specificity of the	4
trial safety and immunogenicity	4
the beginning of the	4
induce protective immunity in	4
bronchitis virus identification of	4
in a phase i	4
an essential role in	4
the reason for the	4
significant difference between the	4
cells were then washed	4
infectious virus were recovered	4
egg and cell produced	4
the icmje criteria for	4
and its implications for	4
vaccine candidates in development	4
patients who were negative	4
performed as described previously	4
adapted to grow in	4
expression of a foreign	4
with a recombinant vaccinia	4
inactivation of the virus	4
the role of complement	4
rates associated with influenza	4
the same set of	4
from birth to days	4
differences in humoral immune	4
of a new caledonia	4
the older age groups	4
were monitored daily for	4
as described above and	4
well tissue culture plate	4
the design of the	4
in beef herds in	4
the wtp for the	4
shown to be effective	4
analysis and comparison with	4
required to determine the	4
the percentage of the	4
and were protected against	4
stable cho cell line	4
to those of the	4
both in vitro and	4
with fetal calf serum	4
that could not be	4
infectious bronchitis virus nucleocapsid	4
use as a vaccine	4
or more of these	4
was clarified by centrifugation	4
in terms of the	4
few weeks of life	4
rift valley fever vaccine	4
to test whether the	4
were incubated for min	4
control and prevention of	4
of the use of	4
in mice and chickens	4
was stopped by adding	4
all ibv vaccinated groups	4
in a volume of	4
on the ability of	4
by the addition of	4
of protective immune responses	4
is worth noting that	4
on behalf of the	4
vaccines were produced with	4
protection from sars coronavirus	4
was not significantly different	4
added and incubated for	4
in agreement with the	4
g and vsv m	4
development and characterization of	4
immune response to influenza	4
are the result of	4
have been isolated from	4
of classical swine fever	4
n protein of the	4
passages in mdck pf	4
may also be important	4
and effectiveness of influenza	4
of a heterologous ebola	4
the determination of the	4
efficacy of a modified	4
that it will be	4
supply of vaccines to	4
attenuated but induces protective	4
over the last years	4
the underlying microbiology of	4
the number of children	4
by the same route	4
genetic stability of the	4
to anticipate potential safety	4
n cd t cell	4
influenza and other viral	4
vaccination against enteric rota	4
under years of age	4
a potent mucosal adjuvant	4
human respiratory syncytial virus	4
aged years and older	4
load and vaccine coverage	4
canine visceral leishmaniasis in	4
cellular immune responses that	4
the modified vaccinia ankara	4
tested positive for influenza	4
group were challenged with	4
dna vaccines have been	4
affected by h n	4
life is affected by	4
and years of age	4
pika as an adjuvant	4
no significant difference was	4
arkansas delmarva poultry industry	4
reaction was stopped by	4
identification and characterization of	4
was read at nm	4
with the increase in	4
addressing the need for	4
by a grant from	4
our data showed that	4
and pac i sites	4
were immunized with different	4
cats in the vaccine	4
the result of the	4
the results are shown	4
and observed under a	4
west nile virus in	4
virus expressing a heterologous	4
use of existing vaccines	4
will be necessary to	4
strong neutralizing antibody responses	4
the cellular immune responses	4
influenza vaccine in children	4
derived infectious bronchitis virus	4
the adaptive immune response	4
the respiratory syncytial virus	4
difference between the two	4
protection against influenza virus	4
the efficacy of a	4
and s proteins were	4
cells was detected in	4
antibody responses to the	4
part of a heterologous	4
the antibody response to	4
using reverse genetic technology	4
of influenza and other	4
at the expense of	4
in the serum of	4
comparable to those induced	4
to be able to	4
served as negative control	4
with particular reference to	4
and antibody assays for	4
was not possible to	4
with human adenovirus type	4
c until further use	4
but induces protective immunity	4
referred to as the	4
is a receptor for	4
from dogs vaccinated with	4
identification of severe acute	4
a heterologous spike gene	4
of japanese encephalitis virus	4
titer was calculated by	4
we found four distinct	4
a final volume of	4
infectious bronchitis coronavirus in	4
and the establishment of	4
for influenza a or	4
case definitions of adverse	4
with the rn protein	4
with the data of	4
in an effort to	4
the human and veterinary	4
lesions were observed in	4
other parts of the	4
arkga p whole genome	4
with rsv subgroup b	4
of pfu per mouse	4
a modified vaccinia virus	4
based vaccine candidates against	4
for evaluating candidate sars	4
compared to the other	4
of a foreign gene	4
monkeys in the immunization	4
the basis of a	4
s s cleavage site	4
or mpl tdm adjuvants	4
of an infectious bronchitis	4
bovine viral diarrhoea virus	4
has been found to	4
viruses were detected in	4
i and class ii	4
cov elicit neutralising antibodies	4
of chicken egg yolk	4
significantly higher than in	4
after washing with pbs	4
at room temperature in	4
rota and coronaviruses in	4
like to thank the	4
associated with influenza and	4
to be used in	4
persons of years and	4
the source of infection	4
of the pathogenic m	4
a phase i study	4
birds in each group	4
a determinant of cell	4
protein of avian infectious	4
intended for use by	4
were more prone to	4
of the th century	4
that alvac can act	4
responses against a variety	4
structural proteins of severe	4
and field strains of	4
been demonstrated to be	4
mucus in the nares	4
the potential to be	4
the chemokines cxcl and	4
the institutional review board	4
of influenza viruses in	4
daily life is affected	4
days after immunization were	4
full s mf n	4
in light of the	4
cp a new caledonia	4
clarified by centrifugation at	4
the rsv g or	4
like infectious bronchitis virus	4
the purified protein was	4
the highest performing countries	4
in the general population	4
an infectious bronchitis virus	4
our results showed that	4
is affected by h	4
to that seen in	4
prior to this study	4
the day and day	4
field strains of cpv	4
the negative control group	4
of the initial appearance	4
ex vivo elispot assays	4
on the development of	4
periods of elevated activity	4
animals vaccinated subcutaneously with	4
the us department of	4
old broiler chicks were	4
was expressed as the	4
mixed with an equal	4
those induced by the	4
there are currently no	4
the beaudette based strains	4
during the first week	4
in the area of	4
of the world health	4
hygiene and tropical medicine	4
represent any agency determination	4
authors attest they meet	4
members of the working	4
cell epitopes in severe	4
incubation time and temperature	4
month data from a	4
use of animals were	4
were partially protected from	4
of the capsid protein	4
acid sequence of the	4
immune responses of pigs	4
respiratory syndrome coronavirus to	4
of the most common	4
the groups that received	4
in favour of mandatory	4
antibody titres in mammary	4
that a single dose	4
and water were provided	4
mutated m and or	4
response to porcine reproductive	4
vaccine for the prevention	4
a h n in	4
in an animal model	4
a modified vaccinia ankara	4
weeks after the third	4
in cd and cd	4
virus vaccines based on	4
chickens inoculated with p	4
expanded programme on immunization	4
had no effect on	4
meet the icmje criteria	4
has been reported to	4
the ohio state university	4
a vaccine based on	4
inactivated by treatment with	4
b and c b	4
of intron enhancing effect	4
number of animals born	4
of veterinary and human	4
phase randomized clinical trial	4
vaccine strain in the	4
a more important role	4
more likely to reject	4
this is the case	4
hi titers against a	4
the vector is derived	4
week after the first	4
in the pathogenicity study	4
short period of time	4
recombinant avian infectious bronchitis	4
strains were recovered from	4
c and d were	4
results are expressed as	4
pandemic h n influenza	4
dependent enhancement of feline	4
vaccine with or without	4
public health impact of	4
different attenuated vsvs with	4
the s s cleavage	4
of the most effective	4
calculated as described previously	4
caused by a novel	4
for a variety of	4
infectious bronchitis virus expressing	4
safety data in pre	4
a potential influenza pandemic	4
the exception of the	4
the cost of a	4
seasonal and avian influenza	4
was calculated by the	4
adherent fraction of the	4
cell responses in sars	4
the negative effect of	4
to be included in	4
of the vaccination program	4
that the inclusion of	4
has been used to	4
was used to determine	4
can serve as an	4
viral titers were determined	4
adults years of age	4
a confluent monolayer of	4
on follicular dendritic cells	4